PIK3CA and hepatocellular carcinoma: This study investigates the in vitro antitumor activity of C. amuricus fractionated extracts against hepatocellular carcinoma cells, coupled with molecular docking analysis targeting key components of the PI3K/AKT/mTOR signaling axis.